RxDoctor Payments Data

Teri Gjerseth, CNM

Advanced Practice Midwife · Tomah, WINPI 1538484407

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AbbVie at 55.6% of the total. Reporting peaked in 2021 at $342 and has fallen 86.9% since, to $45 in 2023.

$678in general payments, 2019–2025

Across 49 payments — averaging $13.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$377
  • Myovant Sciences Inc.$70
  • Pfizer$60
  • Merck$51
  • GSK$35
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$28
  • plus $57 from 4 others

What the payments were for

  • Food & beverage$678100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$678 in reported general payments places this provider in the 80th percentile of 83 advanced practice midwife providers in Wisconsin.

See all advanced practice midwife providers in Wisconsin

Medicare billing

Part B allowed, 2024
$50,472
Medicare patients
163
Services billed
831

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide30$30,323
EliquisApixaban29$17,246
OzempicSemaglutide11$12,334
JardianceEmpagliflozin12$10,737
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,569
Janumet XrSitagliptin Phos/Metformin Hcl11$6,538
Atorvastatin Calcium118$955
Fluticasone-SalmeterolFluticasone Propion/Salmeterol11$828
Levothyroxine Sodium93$817
Metformin Hcl ErMetformin Hcl56$671
Pravastatin Sodium42$589
Sertraline Hcl48$570
Gabapentin37$562
Lisinopril100$559
Losartan Potassium58$534

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$60$17,24629 claims
GSKTrelegy Ellipta$35$7,56911 claims
MerckJanumet Xr$51$6,53811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 83 advanced practice midwife providers in Wisconsin.

Other advanced practice midwife in Tomah

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →